<DOC>
	<DOC>NCT03031678</DOC>
	<brief_summary>The MED-EL EAS Extended Follow-up Study is an extended follow-up of the subjects who were enrolled in the pivotal study to assess long-term safety and device performance.</brief_summary>
	<brief_title>Electric-Acoustic Stimulation Extended Follow-up Post Approval Study</brief_title>
	<detailed_description>The study will be conducted as a prospective, non-controlled, non-randomized, multicenter study at the 14 sites. Up to 68 available subjects who were enrolled in the pivotal study will be invited to participate in the extended follow-up. Study subjects will be followed for a minimum of 5 years post-implantation of the device.</detailed_description>
	<mesh_term>Hearing Loss</mesh_term>
	<mesh_term>Hearing Loss, Sensorineural</mesh_term>
	<criteria>18 years of age or older at the time of implantation Severe to profound sensorineural hearing loss for frequencies greater than 1500 Hz (i.e., threshold no better than 70 dB HL at 20008000 Hz) Lowfrequency thresholds up to and including 500 Hz no poorer than 65 dB HL CNC word recognition score less than or equal to 60% in the ear to be implanted CNC word recognition score less than or equal to 60% in the contralateral ear English spoken as the primary language Conductive, retrocochlear, or central auditory disorder Hearing loss in the ear to be implanted that has demonstrated a recent fluctuation at two or more frequencies of 15 dB in either direction in the last 2 years Any physical, psychological, or emotional disorder that interferes with surgery or the ability to perform on test and rehabilitation procedures Developmental delays or organic brain dysfunction Unrealistic expectations on the part of the subject, regarding the possible benefits, risks, and limitations Unwillingness or inability of the candidate to comply with all investigational requirements</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>